Jeannine Lynch Biography and Net Worth

Vice President of Strategy and Market Access of Lifeward

Jeannine Lynch joins ReWalk Robotics with a focus on completing the building and implementation of ReWalk’s market access and reimbursement programs.

Prior to ReWalk, Ms. Lynch served as Senior Director of Patient Access Services at BioMarin Pharmaceuticals. In addition to her work with BioMarin, Ms. Lynch has worked for industry leaders such as Genentech and Pfizer/Agouron. She has held leadership roles in commercial management, product launches and built customized patient services to address several different rare and ultrarare medical conditions.

Ms. Lynch is a graduate of the University of California Berkeley and holds a Master of Public Health from the University of Michigan. She sits on the Board of Directors for MVP, a non-profit organization to help young people of color prepare, perform, progress, and prosper in their education, leadership and early professional careers.

What is Jeannine Lynch's net worth?: The estimated net worth of Jeannine Lynch is at least $22.91 thousand as of September 2nd, 2025. Ms. Lynch owns 3,838 shares of Lifeward stock worth more than $22,909 as of October 2nd. This net worth approximation does not reflect any other investments that Ms. Lynch may own. Learn More about Jeannine Lynch's net worth.
How do I contact Jeannine Lynch?: The corporate mailing address for Ms. Lynch and other Lifeward executives is 2 Cabot Road, Hudson, MA, 01749. Lifeward can also be reached via phone at (508) 251-1154 and via email at [email protected]. Learn More on Jeannine Lynch's contact information.
Has Jeannine Lynch been buying or selling shares of Lifeward?: Jeannine Lynch has not been actively trading shares of Lifeward during the last ninety days. Most recently, Jeannine Lynch sold 132 shares of the business's stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $7.68, for a transaction totalling $1,013.76. Following the completion of the sale, the vice president now directly owns 3,838 shares of the company's stock, valued at $29,475.84. Learn More on Jeannine Lynch's trading history.

Jeannine Lynch Insider Trading History at Lifeward

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/2/2025	Sell	132	$7.68	$1,013.76	3,838
9/3/2024	Sell	135	$39.60	$5,346.00	3,971
8/2/2024	Sell	148	$46.08	$6,819.84	4,106
7/1/2024	Sell	152	$45.96	$6,985.92	4,255

Jeannine Lynch Buying and Selling Activity at Lifeward

Lifeward Company Overview

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Today's Range

Now: $5.88

$5.90

$6.35

50 Day Range

MA: $7.21

$6.03

$7.89

2 Week Range

Now: $5.88

$4.14

$10.20

Volume

3,214 shs

Average Volume

14,510 shs

Market Capitalization

$16.64 million

P/E Ratio

N/A

Dividend Yield